Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(7 sites)

United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York